Beruflich Dokumente
Kultur Dokumente
PGF2 Stimulates breakdown on corpus luteum (luteolysis): Animals • Stimulates uterine smooth muscle
contraction • Bronchial constrictor
PGI1 Potent inhibitor of platelet aggregation • Potent transient CV vasodilator, then vasodilator • Bronchial
dilator • Uterine relaxant • Sensitize/amplify nerve pain response
TXA2 Potent inducer of platelet aggregation • Potent vasconstrictor (bronchioles, renal) • Decreases cAMP
levels in platelets • Stimulates the release of ADP and 5-HT from platelets
ROLE OF PROSTAGLANDINS IN PREGNANCY
PGE2:
In-vivo PGE2 contracts both a pregnant and non-pregnant uterus.
In-vitro, PGE2 contracts the pregnant uterus while relaxing the non-
pregnant uterus.
Promotes cervical ripening.
PGF2:
PGF2 is a potent vasoconstrictor
Increases intracellular calcium, thus increasing myometrial contractility.
PGI2 (Prostayclin):
It is a vasodilator which inhibits uterine contractility.
PROSTAGLANDIN ANALOGUES USED IN
PREGNANCY
Prostaglandin E1(Misoprostol)
• Misoprostol is a synthetic PGE1 analogue approved by FDA 12yrs ago to prevent
ulcers in people under NSAID therapy.
• It increases the secretion of protective mucus that lines the GIT and increases mucosal
integrity by increasing mucosal blood flow.
• Misoprostol has a half life of 20-40 mins and is majorly excreted renally (56-73%)
• Other side effects: anemia, cardiac disarrhythmmia, chest pain, hearing loss,
myocardial infarction, thromboembolic disorder.
DRUG INTERACTIONS
• Crofelemer
• Eluxadoline
TOXICITY
• Acute overdosing is rare but may cause hyperthermia, increased PR and RR. In mild to
moderate toxicity, the overdose effects will be an extension of the adverse effects;
abdominal cramping, diarrhea, headache, dizziness, uterine contractions and bleeding
may occur. In severe toxicities, hypertension, tachycardia, fever, tremors, rabdomyolysis,
renal insufficiency, abnormal LFT can occur.
MANAGEMENT
• Mild to moderate toxicity: Close observation with only symptomatic treatment.
• It is also used for the management of missed abortion or intrauterine fetal death upto 28
weeks gestational age.
• Hydatidiform mole, benign: 20mg suppository into the vagina. Repeat every 3-5hr intervals
upto 2 days.
ADRs:
Diarrhea(40%); Nausea(33%); vomiting(66%); Headache(10%); abnormal fetal HR(17%),
fetal distress(3.8%); Hypotension; Hyperthermia.
DRUG INTERACTIONS
The activity of oxytocic agents (ergonovine, methylergonovine, oxytocin) may be
augmented by the prostaglandins and thus concomitant use is not recommended.
CONTRAINDICATIONS
In active cardiac, hepatic or pulmonary disease; Acute PID; h/o cesarean
Drug Interactions
The activity of oxytocic agents may be augmented by the prostaglandins and thus
concomitant use is not recommended.